Marigot Ltd.
8
0
0
7
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 8 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 7 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (8)
Combination Plant-Based Protein and Marine-Based Multi-Mineral Supplement and Bone Remodeling in Young Adults
Role: collaborator
Bioavailability of Plant Protein Amino Acids
Role: collaborator
The Effect of a Plant Protein Isolate on Muscle Protein Synthesis in Humans at Rest and After Resistance Exercise
Role: collaborator
The Marigot Osteoarthritis Nutritional Intervention (MOANi) Trial
Role: collaborator
Hydrocolloids as Functional Food Ingredients for Gut Health
Role: collaborator
A Study to Determine if Aquamin (as AquaCal and AquaPT) Improves Digestive Discomfort
Role: collaborator
Effects of Aquamin F on NSAID Dose Reduction in Osteoarthritis of the Knee
Role: lead
Effects of Aquamin F on Osteoarthritis of the Knee
Role: lead
All 8 trials loaded